English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 853924      Online Users : 1332
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    專利 [0/42]
    期刊論文 [141/141]

    Collection Statistics

    近3年內發表的文件:1(2.08%)
    含全文筆數:30(62.50%)

    文件下載次數統計
    下載大於0次:30(100.00%)
    下載大於100次:30(100.00%)
    檔案下載總次數:17857(17.58%)

    最後更新時間: 2024-11-28 16:04


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 26-48 of 48. (2 Page(s) Totally)
    << < 1 2 
    View [10|25|50] records per page

    DateTitleRelation
    2013-04 Design and synthesis of Aurora kinase inhibitors as anticancer agents Abstracts of Papers - American Chemical Society. 2013 Apr;245:Article number 301-MEDI.
    2012-03-25 Design, synthesis, and SAR studies of duel FLT-3 and Aurora kinase inhibitors Abstracts of Papers - American Chemical Society. 2012 Mar 25;243:Article number 48-MEDI.
    2011-09-23 BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo European Journal of Cancer. 2011 Sep 23;47:S127.
    2011-04 Antivascular activities of novel tubulin binding agent BPR0L075 Cancer Research. 2011 Apr;71:Abstract number 5309.
    2011-03-27 Design and synthesis of potent Aurora kinase inhibitors Abstracts of Papers - American Chemical Society. 2011 Mar 27;241:258-MEDI.
    2011-03 SAR studies of quinoline derivatives as novel anti-influenza agents Abstracts of Papers - American Chemical Society. 2011 Mar;241:81-MEDI.
    2011-03 Potent EGFR tyrosine kinase inhibitors as anticancer agents Abstracts of Papers - American Chemical Society. 2011 Mar;241:257-MEDI.
    2010-08 Lead optimization of furanopyrimidine Aurora kinase inhibitors: Development of in vivo active agents in tumor xenograft models Abstracts of Papers - American Chemical Society. 2010 Aug;240:MEDI 332.
    2009-09 Fast-forwarding kinase drug discovery: aurora and EGFR kinase inhibitor lead development EJC Supplements. 2009 Sep;7(2):96.
    2009-05 Down-regulation of survivin enhances sensitivity to BPROL075 in human cancer cells via caspase-independent mechanisms Cancer Research. 2009 May;69:Abstract number 5542.
    2009-03 Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors Abstracts of Papers - American Chemical Society. 2009 Mar;237:MEDI 221.
    2007-07 Anti-influenza drug discovery Drugs of the Future. 2007 Jul;32(Suppl. A):97.
    2007-07 From bench to drug candidate: Design and synthesis of 5,6-fused heteroaromatics as anticancer agents Drugs of the Future. 2007 Jul;32(Suppl. A):34-35.
    2006-11 Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity EJC Supplements. 2006 Nov;4(12):59.
    2006-09 MEDI 416-3- 2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino -3-methyl-butyr amide analogs as DPP-IV inhibitors for the treatment of type-II diabetes Abstracts of Papers - American Chemical Society. 2006 Sep;232:MEDI 416.
    2005-03 Promazine analogues as potential anti SARS-CoV drugs Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U168.
    2005-03 Design, synthesis and sar of indole-based PPAR agonists Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141.
    2005-03 Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents Abstracts of Papers of the American Chemical Society. 2005 Mar;229(Part 2):U141.
    2004-09 Drug design of BPR0L075 as an anticancer agent World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203.
    2004-08-22 Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents Abstracts of Papers - American Chemical Society. 2004 Aug 22;228:U924.
    2004-07 Drug design for BPR0L075 as an anticancer agent Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul.
    2003 The synthetic 1-aroylindoles and 3-aroylindoles derivatives, combretastatin A-4 analogues, as a novel class of potent anticancer agents 2003 PSROC Annual Meeting. 2003.
    2002-08 Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents Abstracts of Papers of the American Chemical Society. 2002 Aug;224:076-MEDI.

    Showing items 26-48 of 48. (2 Page(s) Totally)
    << < 1 2 
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback